Anna Leśniak

3.8k total citations · 2 hit papers
75 papers, 3.1k citations indexed

About

Anna Leśniak is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Anna Leśniak has authored 75 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cellular and Molecular Neuroscience, 29 papers in Molecular Biology and 19 papers in Physiology. Recurrent topics in Anna Leśniak's work include Neuropeptides and Animal Physiology (25 papers), Pain Mechanisms and Treatments (17 papers) and Chemical Synthesis and Analysis (9 papers). Anna Leśniak is often cited by papers focused on Neuropeptides and Animal Physiology (25 papers), Pain Mechanisms and Treatments (17 papers) and Chemical Synthesis and Analysis (9 papers). Anna Leśniak collaborates with scholars based in Poland, Sweden and Ireland. Anna Leśniak's co-authors include Kenneth A. Dawson, Anna Salvati, Christoffer Åberg, Marco P. Monopoli, Federico Fenaroli, Maria José Santos-Martínez, Marek W. Radomski, Iseult Lynch, Mariusz Sacharczuk and Andrzej W. Lipkowski and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Anna Leśniak

72 papers receiving 3.1k citations

Hit Papers

Effects of the Presence or Absence of a Protein Corona on... 2012 2026 2016 2021 2012 2013 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Leśniak Poland 18 1.3k 1.1k 956 867 265 75 3.1k
Virgilio Brunetti Italy 26 1.7k 1.3× 905 0.8× 1.3k 1.3× 983 1.1× 345 1.3× 41 3.6k
Aleksandr Käkinen Australia 37 1.7k 1.3× 838 0.8× 781 0.8× 1.2k 1.4× 150 0.6× 68 3.8k
Seong Soo A. An South Korea 41 969 0.7× 504 0.5× 884 0.9× 1.9k 2.2× 117 0.4× 239 5.7k
Kyung Jin Lee South Korea 39 1.2k 0.9× 729 0.7× 1.1k 1.2× 526 0.6× 376 1.4× 218 4.5k
Chenchen Li China 36 1.1k 0.8× 734 0.7× 1.3k 1.4× 1.5k 1.8× 167 0.6× 203 4.4k
Zhenzhen Huang China 33 2.4k 1.8× 316 0.3× 736 0.8× 1.8k 2.1× 451 1.7× 138 4.4k
P.V. Mohanan India 34 1.2k 0.9× 562 0.5× 1.3k 1.3× 592 0.7× 100 0.4× 129 3.4k
Alessandro Pezzella Italy 39 1.1k 0.8× 725 0.7× 755 0.8× 792 0.9× 436 1.6× 153 5.7k
Jing Wen China 44 667 0.5× 796 0.7× 725 0.8× 1.7k 2.0× 314 1.2× 184 5.2k

Countries citing papers authored by Anna Leśniak

Since Specialization
Citations

This map shows the geographic impact of Anna Leśniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Leśniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Leśniak more than expected).

Fields of papers citing papers by Anna Leśniak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Leśniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Leśniak. The network helps show where Anna Leśniak may publish in the future.

Co-authorship network of co-authors of Anna Leśniak

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Leśniak. A scholar is included among the top collaborators of Anna Leśniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Leśniak. Anna Leśniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andreozzi, Giorgia, Maria Rosaria Ambrosio, Elisa Magli, et al.. (2023). Design, Synthesis and Biological Evaluation of Novel N-Arylpiperazines Containing a 4,5-Dihydrothiazole Ring. Pharmaceuticals. 16(10). 1483–1483.
2.
Ostrowska, Kinga, et al.. (2023). New Piperazine Derivatives of 6-Acetyl-7-hydroxy-4-methylcoumarin as 5-HT1A Receptor Agents. International Journal of Molecular Sciences. 24(3). 2779–2779. 6 indexed citations
3.
4.
Krząścik, Paweł, et al.. (2021). Disulfiram Abrogates Morphine Tolerance—A Possible Role of µ-Opioid Receptor-Related G-Protein Activation in the Striatum. International Journal of Molecular Sciences. 22(8). 4057–4057. 3 indexed citations
6.
Leśniak, Anna, et al.. (2021). Tożsamość miejsca w kontekście architektonicznym. 2021(1). 79–90. 1 indexed citations
7.
8.
Leśniak, Anna, et al.. (2018). Review of research on alcohol dependence in a model of mice selected for high and low stress-induced analgesia. SHILAP Revista de lepidopterología. 12(3). 217–222. 1 indexed citations
9.
Leśniak, Anna, Christian Sköld, Maria Karlgren, et al.. (2018). An imidazole based H-Phe-Phe-NH2 peptidomimetic with anti-allodynic effect in spared nerve injury mice. Bioorganic & Medicinal Chemistry Letters. 28(14). 2446–2450. 3 indexed citations
11.
Leśniak, Anna, Michał Korostyński, Piotr Religa, et al.. (2017). Delta-opioid receptor antagonism leads to excessive ethanol consumption in mice with enhanced activity of the endogenous opioid system. Neuropharmacology. 118. 90–101. 15 indexed citations
12.
Kleczkowska, Patrycja, Emmanuel Hermans, Piotr Kossoń, et al.. (2016). Antinociceptive effect induced by a combination of opioid and neurotensin moieties vs. their hybrid peptide [Ile 9 ]PK20 in an acute pain treatment in rodents. Brain Research. 1648(Pt A). 172–180. 16 indexed citations
13.
Leśniak, Anna, et al.. (2016). Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine. European Journal of Pharmaceutical Sciences. 89. 39–49. 11 indexed citations
14.
Leśniak, Anna, et al.. (2016). Antinociceptive effect of co-administered NMDA and histamine H4 receptor antagonists in a rat model of acute pain. Pharmacological Reports. 69(2). 222–228. 7 indexed citations
15.
Krizbai, István A., Anna Leśniak, M Beresewicz, et al.. (2014). Role of the blood-brain barrier in differential response to opioid peptides and morphine in mouse lines divergently bred for high and low swim stress-induced analgesia. Acta Neurobiologiae Experimentalis. 74(1). 26–32. 13 indexed citations
16.
Skurzak, H, Sergiusz Markowicz, Anna Leśniak, et al.. (2013). Original article Opioid agonist – tachykinin antagonist as a new analgesic with adjuvant anticancer properties. Folia Neuropathologica. 2(2). 132–139. 11 indexed citations
17.
Sacharczuk, Mariusz, et al.. (2012). Distinct Susceptibility to Inoculated Melanoma and Sensitivity to Cancer Pain in Mouse Lines With High and Low Sensitivity to Stress. Journal of Environmental Pathology Toxicology and Oncology. 31(2). 167–177. 6 indexed citations
18.
Leśniak, Anna & Andrzej W. Lipkowski. (2011). Opioid peptides in peripheral pain control. Acta Neurobiologiae Experimentalis. 71(1). 129–138. 36 indexed citations
19.
Leśniak, Anna, et al.. (2008). Canine Olfactory Receptor Gene Polymorphism and Its Relation to Odor Detection Performance by Sniffer Dogs. Journal of Heredity. 99(5). 518–527. 61 indexed citations
20.
Leśniak, Anna, et al.. (1996). Przekształcenia własnościowe państwowego sektora rolnego.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026